Sectors & Industries HealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2024)
Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research

Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Exchange	Industry	Market Cap	Price	1d %	EBITDA	P/E	D/E
FONR	FONAR CORP	NASDAQ	Diagnostics & Research	$113.28M	$16.88	-3.43%	$25.75M	8.93x	0.28
STRR	STAR EQUITY HOLDINGS INC	NASDAQ	Diagnostics & Research	$14.33M	$0.90	-1.85%	$26.87M	0.56x	0.16
ICLR	ICON PLC	NASDAQ	Diagnostics & Research	$26.08B	$315.39	0.11%	$1.62B	38.00x	0.81
NEOG	NEOGEN CORP	NASDAQ	Diagnostics & Research	$2.67B	$12.33	-0.80%	$188.76M	616.50x	0.46
IDXX	IDEXX LABORATORIES INC	NASDAQ	Diagnostics & Research	$42.10B	$509.82	1.80%	$1.24B	48.88x	1.14
CRL	CHARLES RIVER LABORATORIES INTERNATIONAL INC	NYSE	Diagnostics & Research	$11.75B	$228.12	-0.86%	$1.00B	26.68x	1.22
ENZ	ENZO BIOCHEM INC	NYSE	Diagnostics & Research	$53.27M	$1.04	0.00%	$33.74M	1.55x	0.40
DGX	QUEST DIAGNOSTICS INC	NYSE	Diagnostics & Research	$15.38B	$138.42	0.19%	$1.70B	18.38x	1.16
QGEN	QIAGEN NV	NYSE	Diagnostics & Research	$9.76B	$43.61	0.07%	$680.17M	29.71x	0.61
TMO	THERMO FISHER SCIENTIFIC INC	NYSE	Diagnostics & Research	$226.37B	$593.03	2.61%	$11.37B	37.89x	1.13
SHC	SOTERA HEALTH CO	NASDAQ	Diagnostics & Research	$3.13B	$11.04	-2.56%	$426.24M	58.11x	6.13
LAB	STANDARD BIOTOOLS INC	NASDAQ	Diagnostics & Research	$893.14M	$2.40	-0.41%	-$76.45M	-2.38x	0.35
A	AGILENT TECHNOLOGIES INC	NYSE	Diagnostics & Research	$43.89B	$149.76	3.18%	$1.69B	35.49x	0.77
DHR	DANAHER CORP	NYSE	Diagnostics & Research	$187.68B	$253.38	0.78%	$7.54B	42.51x	0.56
FLGT	FULGENT GENETICS INC	NASDAQ	Diagnostics & Research	$650.85M	$21.75	-0.18%	-$127.63M	-3.90x	0.09
MEDP	MEDPACE HOLDINGS INC	NASDAQ	Diagnostics & Research	$12.09B	$390.19	-2.26%	$405.89M	38.37x	1.67
CSTL	CASTLE BIOSCIENCES INC	NASDAQ	Diagnostics & Research	$669.20M	$24.24	-0.74%	-$17.87M	-21.26x	0.14
LH	LABORATORY CORP OF AMERICA HOLDINGS	NYSE	Diagnostics & Research	$17.51B	$207.67	0.74%	$1.55B	40.72x	1.08
EXAS	EXACT SCIENCES CORP	NASDAQ	Diagnostics & Research	$9.87B	$53.51	-1.18%	$32.77M	-40.54x	1.04
NTRA	NATERA INC	NASDAQ	Diagnostics & Research	$12.93B	$105.29	10.19%	-$311.83M	-33.75x	0.85
PRE	PRENETICS GLOBAL LTD	NASDAQ	Diagnostics & Research	$72.25M	$5.92	10.04%	-$55.20M	-1.06x	0.21
RVTY	REVVITY INC	NYSE	Diagnostics & Research	$12.93B	$104.80	0.44%	$665.40M	85.90x	0.71
PRPO	PRECIPIO INC	NASDAQ	Diagnostics & Research	$8.63M	$6.04	4.52%	-$4.32M	-1.34x	0.25
SERA	SERA PROGNOSTICS INC	NASDAQ	Diagnostics & Research	$302.37M	$9.26	-5.41%	-$32.31M	-8.65x	0.39
DRIO	DARIOHEALTH CORP	NASDAQ	Diagnostics & Research	$46.22M	$1.57	-5.42%	-$54.38M	-0.81x	0.66
WAT	WATERS CORP	NYSE	Diagnostics & Research	$20.83B	$351.11	4.37%	$979.13M	34.39x	2.59
OLK	OLINK HOLDING AB (PUBL)	NASDAQ	Diagnostics & Research	$2.90B	$23.32	-0.34%	-$20.05M	-93.28x	0.20
IQV	IQVIA HOLDINGS INC	NYSE	Diagnostics & Research	$42.65B	$234.08	2.13%	$3.27B	31.55x	3.19
DMTK	DERMTECH INC	NASDAQ	Diagnostics & Research	$21.64M	$0.63	0.81%	-$95.04M	-0.20x	1.13
NEO	NEOGENOMICS INC	NASDAQ	Diagnostics & Research	$2.01B	$15.77	1.74%	$1.33M	-23.89x	0.78
TWST	TWIST BIOSCIENCE CORP	NASDAQ	Diagnostics & Research	$2.47B	$42.37	-1.92%	-$155.32M	-12.61x	0.26
MTD	METTLER TOLEDO INTERNATIONAL INC	NYSE	Diagnostics & Research	$32.25B	$1,510.25	17.04%	$1.17B	42.13x	-21.69
ACRS	ACLARIS THERAPEUTICS INC	NASDAQ	Diagnostics & Research	$83.38M	$1.17	-4.49%	-$76.72M	-1.07x	0.23
OCX	ONCOCYTE CORP	NASDAQ	Diagnostics & Research	$23.91M	$2.89	0.70%	-$26.05M	-0.77x	2.41
BGLC	BIONEXUS GENE LAB CORP	NASDAQ	Diagnostics & Research	$10.25M	$0.58	-2.52%	-$2.49M	-3.17x	0.18
BNR	BURNING ROCK BIOTECH LTD	NASDAQ	Diagnostics & Research	$81.24M	$0.79	1.80%	-$71.63M	-0.90x	0.35
XWEL	XWELL INC	NASDAQ	Diagnostics & Research	$7.61M	$1.82	-2.67%	-$24.16M	-0.27x	1.39
RDNT	RADNET INC	NASDAQ	Diagnostics & Research	$4.08B	$55.25	3.14%	$281.33M	167.42x	2.17
XGN	EXAGEN INC	NASDAQ	Diagnostics & Research	$27.06M	$1.57	11.35%	-$18.21M	-1.17x	1.51
PSNL	PERSONALIS INC	NASDAQ	Diagnostics & Research	$81.54M	$1.57	-4.85%	-$79.45M	-0.83x	0.62
CDNA	CAREDX INC	NASDAQ	Diagnostics & Research	$772.40M	$14.83	34.09%	-$175.06M	-4.35x	0.77
STIM	NEURONETICS INC	NASDAQ	Diagnostics & Research	$75.29M	$2.51	0.80%	-$19.49M	-2.64x	2.75
NDRA	ENDRA LIFE SCIENCES INC	NASDAQ	Diagnostics & Research	$3.30M	$0.30	-1.32%	-$9.78M	-0.19x	0.19
ME	23ANDME HOLDING CO	NASDAQ	Diagnostics & Research	$240.01M	$0.50	-2.55%	-$490.64M	-0.45x	0.61
GH	GUARDANT HEALTH INC	NASDAQ	Diagnostics & Research	$2.74B	$22.37	15.07%	-$414.22M	-5.65x	23.96
CHEK	CHECK-CAP LTD	NASDAQ	Diagnostics & Research	$12.81M	$2.19	-1.35%	-$19.08M	-0.73x	0.06
ULS	UL SOLUTIONS INC	NYSE	Diagnostics & Research	N/A	$36.68	0.33%	$519.00M	28.22x	3.15
MYGN	MYRIAD GENETICS INC	NASDAQ	Diagnostics & Research	$2.31B	$25.47	0.87%	-$163.70M	-9.10x	0.46
PRPH	PROPHASE LABS INC	NASDAQ	Diagnostics & Research	$96.35M	$5.05	2.64%	-$23.50M	-3.71x	1.01
AWH	ASPIRA WOMEN's HEALTH INC	NASDAQ	Diagnostics & Research	$36.66M	$2.97	-3.26%	-$16.50M	-1.64x	-3.65
NOTV	INOTIV INC	NASDAQ	Diagnostics & Research	$96.97M	$3.76	-9.62%	$59.57M	-2.89x	2.29
VNRX	VOLITIONRX LTD	NYSEMKT	Diagnostics & Research	$68.03M	$0.83	2.35%	-$33.68M	-1.66x	-4.70
MDXH	MDXHEALTH SA	NASDAQ	Diagnostics & Research	$7.56M	$2.77	-4.48%	-$21.40M	-0.20x	-126.12
GENE	GENETIC TECHNOLOGIES LTD	NASDAQ	Diagnostics & Research	$528.61k	$2.29	0.00%	N/A	-0.77x	0.76
MYNZ	MAINZ BIOMED NV	NASDAQ	Diagnostics & Research	$13.97M	$0.66	0.15%	-$24.62M	-0.41x	3.74
APDN	APPLIED DNA SCIENCES INC	NASDAQ	Diagnostics & Research	$3.40M	$3.45	-7.75%	-$11.10M	-0.20x	-194.21
BIAF	BIOAFFINITY TECHNOLOGIES INC	NASDAQ	Diagnostics & Research	$23.03M	$2.00	-0.99%	-$7.63M	-2.20x	0.69
ILMN	ILLUMINA INC	NASDAQ	Diagnostics & Research	$17.61B	$110.53	-0.74%	-$640.00M	-13.56x	0.75
PMD	PSYCHEMEDICS CORP	NASDAQ	Diagnostics & Research	$14.64M	$2.55	-1.54%	-$768.00k	-3.54x	0.85
OPK	OPKO HEALTH INC	NASDAQ	Diagnostics & Research	$892.15M	$1.28	1.59%	-$128.11M	-3.66x	0.58
TRIB	TRINITY BIOTECH PLC	NASDAQ	Diagnostics & Research	$13.03M	$1.70	3.03%	-$11.25M	-0.53x	-3.48
MMA	ALTA GLOBAL GROUP LTD	NYSEMKT	Diagnostics & Research	N/A	$3.79	11.80%	-$16.12M	-0.72x	-0.55
BDSX	BIODESIX INC	NASDAQ	Diagnostics & Research	$181.20M	$1.58	1.94%	-$32.10M	-2.93x	-16.85
ISPC	ISPECIMEN INC	NASDAQ	Diagnostics & Research	$2.39M	$0.24	-11.11%	-$9.41M	-0.19x	0.84
CNTG	CENTOGENE NV	NASDAQ	Diagnostics & Research	$10.76M	$0.39	-2.01%	-$44.39M	-0.25x	-5.72
TTOO	T2 BIOSYSTEMS INC	NASDAQ	Diagnostics & Research	$32.49M	$3.70	15.83%	-$38.59M	-0.32x	-1.66

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in May 2024?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Fonar (NASDAQ:FONR)

Fonar (NASDAQ:FONR) is the top diagnostic & research stock with a Zen Score of 47, which is 21 points higher than the diagnostic & research industry average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Fonar has seen its stock return 1.14% over the past year, underperforming other diagnostic & research stocks by -8 percentage points.

2. Star Equity Holdings (NASDAQ:STRR)

Star Equity Holdings (NASDAQ:STRR) is the second best diagnostic & research stock with a Zen Score of 46, which is 20 points higher than the diagnostic & research industry average of 26. It passed 18 out of 38 due diligence checks and has strong fundamentals. Star Equity Holdings has seen its stock return 3.91% over the past year, underperforming other diagnostic & research stocks by -5 percentage points.

3. Neogen (NASDAQ:NEOG)

Neogen (NASDAQ:NEOG) is the third best diagnostic & research stock with a Zen Score of 43, which is 17 points higher than the diagnostic & research industry average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Neogen has seen its stock lose -28.1% over the past year, underperforming other diagnostic & research stocks by -37 percentage points.

Neogen has an average 1 year price target of $17.00, an upside of 37.88% from Neogen's current stock price of $12.33.

Neogen stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Neogen, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the diagnostic & research stocks with highest dividends?

Out of 7 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Qiagen Nv (NYSE:QGEN)

Qiagen Nv (NYSE:QGEN) has an annual dividend yield of 2.94%, which is 2 percentage points higher than the diagnostic & research industry average of 1.34%.

Qiagen Nv's dividend payout ratio of 87.2% indicates that its dividend yield is sustainable for the long-term.

2. Quest Diagnostics (NYSE:DGX)

Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2.08%, which is 1 percentage points higher than the diagnostic & research industry average of 1.34%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 38.2% indicates that its dividend yield is sustainable for the long-term.

3. Laboratory Of America Holdings (NYSE:LH)

Laboratory Of America Holdings (NYSE:LH) has an annual dividend yield of 1.39%, which is the same as the diagnostic & research industry average of 1.34%. Laboratory Of America Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Laboratory Of America Holdings's dividend has not shown consistent growth over the last 10 years.

Laboratory Of America Holdings's dividend payout ratio of 56.5% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks up?

Diagnostic & research stocks were up 5.11% in the last day, and up 7.27% over the last week. Caredx was the among the top gainers in the diagnostics & research industry, gaining 34.09% yesterday.

CareDX shares are trading higher after the company reported better-than-expected Q1 financial results and issued FY24 revenue guidance above estimates.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Star Equity Holdings (NASDAQ:STRR)

Star Equity Holdings (NASDAQ:STRR) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Star Equity Holdings has a valuation score of 71, which is 54 points higher than the diagnostic & research industry average of 17. It passed 5 out of 7 valuation due diligence checks.

Star Equity Holdings's stock has gained 3.91% in the past year. It has underperformed other stocks in the diagnostic & research industry by -5 percentage points.

2. Enzo Biochem (NYSE:ENZ)

Enzo Biochem (NYSE:ENZ) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Enzo Biochem has a valuation score of 71, which is 54 points higher than the diagnostic & research industry average of 17. It passed 5 out of 7 valuation due diligence checks.

Enzo Biochem's stock has dropped -60.9% in the past year. It has underperformed other stocks in the diagnostic & research industry by -70 percentage points.

3. Fonar (NASDAQ:FONR)

Fonar (NASDAQ:FONR) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Fonar has a valuation score of 71, which is 54 points higher than the diagnostic & research industry average of 17. It passed 5 out of 7 valuation due diligence checks.

Fonar's stock has gained 1.14% in the past year. It has underperformed other stocks in the diagnostic & research industry by -8 percentage points.

Are diagnostic & research stocks a good buy now?

55.1% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 3.98% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 37.39x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.